Rebalix
SPDR · sheet of 20 October 2026
SPDR · sheet of 20 October 2026ETF sheet · official issuer and register data
State Street® SPDR® Bloomberg Emerging Markets Local Bond UCITS ETF (Acc)
EMLA · IE00BFWFPY67 · USD · domicile Ireland
Bonds · Government · Broad (all maturities) · Emerging marketsSFDR art. 6 (inferred)
Index tracked: Bloomberg Emerging Markets Local Currency Liquid Government Bond Index
- TER
- 0.55%+ trans. 0.00%
- Fund size
- 1.5 bn EUR
- Tracking difference
- −0.90%3-year avg
- 🇮🇹 tax rate
- 13.27%white list 94.33%
- Replication
- Physical (sampled)
- Income
- Accumulating
- Duration
- 6.09 yrsmedium (3–7 years)
Launch 19 Jul 2018 · costs from the KID as of 2 Oct 2026 · 625 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 5 Aug 2026
Investment objective The objective of the Fund is to track the performance of the debt markets in emerging market countries for liquid local currency securities. The Fund seeks to track the performance of the Bloomberg Emerging Markets Local Currency Liquid Government Bond Index (the "Index") as closely as possible. The Fund is an index tracking fund (also known as a passively managed fund). Investment policies The Fund invests primarily in securities included in the Index. These include bonds issued by governments in emerging market countries. These…
Performance since series start (in euro) — base 100
20 Jul 2018 → 16 Oct 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +5.6% |
| 3 years | +15.7% |
| 5 years | +12.4% |
| 10 years | series too young |
| Since series start | +22.1% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 6.42% | 6.13% | 6.88% |
| Max drawdown | −6.22% | −7.61% | −20.73% |
| Sharpe | -0.01 | 0.66 | -0.07 |
| Sortino | -0.02 | 1.01 | -0.10 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EMLA · IE00BFWFPY671
RebalixEMLA · IE00BFWFPY67 · sheet of 20 October 2026
Tracking difference — year by year
Fund minus index, complete calendar years · declared by the issuer
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +15.70% | +16.65% | −0.95% |
| 2024 | −3.05% | −2.22% | −0.84% |
| 2023 | +10.44% | +11.34% | −0.90% |
| 2022 | −10.72% | −10.24% | −0.49% |
| 2021 | −8.42% | −7.80% | −0.62% |
Fixed income — as declared by the issuer
Factsheet · 30 Sept 2026 · investment-grade share (BBB−/Baa3 and above): 81.6%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Holdings
Portfolio as declared by the issuer · 30 Sept 2026 · 625 securities · top-10 weight = 7.5%
Countries (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
EMLA · Borsa Italiana (ETFplus)
SPFA · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
EMDA · SIX Swiss Exchange
+ 4 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BFWFPY67
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BFWFPY67
Series, distributions, holdings and documents refresh daily.
Sheet produced on 20 October 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · EMLA · IE00BFWFPY672